Shenzhen-based Chinese gene sequencing giant BGI Genomics Co ., Ltd is making another try for a listing on the ChiNext board of the Shenzhen Stock Exchange, seeking to raise US$250 million by issuing 40 million new shares, after its previous application.
The transaction, Taikang's largest investment for healthcare assets , comes at a time when NorthStar Realty is preparing for a three-way merger with NorthStar Asset Management LLC and private equity firm Colony Capital Inc . At the end of 2014, there.
SINGAPORE, Aug. 30, 2017 /PRNewswire/ -- As traditional methods of trading continue to be challenged, 2017 is the year (and time) to "re-think traditional trading". Returning after a successful inaugural year, this year's Fixed Income Leaders Summit.
Cindat, backed by investors including China Cinda Asset Management Co . and Taikang Life Insurance and its affiliate, is the senior preferred joint venture partner holding a 70.0% ownership stake, while Hersha retains a 30.0% equity interest, as well as.
Further cost cutting and divestment of non-core assets such as the pipeline segment looks increasingly likely as the company moves to repair ... PetroChina brought in domestic fund management firm Taikang Asset Management Co Ltd and Beijing Guolian Energy.
Chinese insurer Taikang buys leading stake in Sotheby's Nikkei Asian Review.
Law360, New York (October 24, 2016, 3:49 PM EDT) -- Chinese tourism and logistics company HNA Group Co . Ltd . on Monday said that it has agreed to purchase a 25 percent stake in Hilton Worldwide Holdings Inc. from private equity giant The Blackstone .
Established in 2013, Ashmore-CCSC is a Sino-foreign asset-management joint venture (JV) between the Central China Securities Co (CCSC) and the Ashmore Group, whereby CCSC owns a 51% stake in the JV while Ashmore holds the remaining 49%. Ashmore-CCSC is.
Company receives $57M to Further Advance Biologics Development and Clinical Trials HANGZHOU, China, Aug. 8, 2017 /PRNewswire/ -- Dedicated to developing global antibody and recombinant protein bio-therapeutics, Hangzhou Just Biotherapeutics, Ltd. (Just.
He takes on his role with the 3,000 person company after serving more than two years with Taikang Asset Management , including 11 months as a director with the asset management affiliate of China's Taikang Life. The leadership role at Riverside Group.